Display search results for ** instead (50 products)
19 Sep 2018  |  North America
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
25 Jul 2018  |  North America
Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets
Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...
01 Aug 2018  |  Europe
Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve
This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux. The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence o...
21 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022
Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations
Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...
27 Jun 2018  |  Global
Opportunities Lie in the Integration of Big Data, AI, Aging-in-Place, Disease Management, and Wellness to Optimize a Single Consumer Health Platform
Smart homes are no longer an emerging concept. Consumers are not only warming up to the idea but also buying home automation products. Smart speakers seem to be the favorite, with sales jumping from a meager 6 million units in 2016 to a whopping 33.2 million units in 2017. The developing ecosystem of home automation products that each of these curr...
27 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022
The Market for Endoscope Reprocessing Solutions Would be Driven by Increasing Procedural Volumes, Coupled with Increased Demand for Newer Installations as Well as Replacements
The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endosco...
29 Jun 2018  |  Global
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
29 Jun 2018  |  North America
Using Cutting-edge Digital Technologies to Improve Patient Engagement and Adherence
Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...
29 Jun 2018  |  Global
Exploring Viable Strategies to Reduce Drug-Device Competitive Initiatives that can Deliver the Right Value of Care for Clinically Safe & Effective Management of Pain Disorders
Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...
05 Oct 2018  |  North America
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...